ACADIA Pharmaceuticals Inc. vs Vital Farms Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Vital Farms Inc trades at $11.57 (market cap $496.50M). The key difference: ACADIA Pharmaceuticals Inc. is far larger — about 10.2× Vital Farms Inc's market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Vital Farms Inc nearer its low. Which is the better fit depends on your goals.
| ACAD | VITL | |
|---|---|---|
Market Cap | $5.07B | $496.50M |
Sector | Health | Consumer Staples |
52-Week High | $29.41 | $52.41 |
52-Week Low | $20.06 | $8.28 |
Enterprise Value | $4.19B | $583.51M |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →